Myriad Genetics diskutieren
Myriad Genetics
WKN: 897518 / Symbol: MYGN / Name: Myriad Genetics / Aktie / Ausrüstung & Versorgung / Mid Cap /
18,30 €
9,58 %
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target raised by analysts at Raymond James from $25.00 to $27.00. They now have an "outperform" rating on the stock.
Ratings data for MYGN provided by MarketBeat
Myriad Genetics, Inc. (NASDAQ: MYGN) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "sell" rating to a "buy" rating. They now have a $25.00 price target on the stock, up previously from $18.00.
Ratings data for MYGN provided by MarketBeat
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $25.00 to $28.00. They now have a "buy" rating on the stock.
Ratings data for MYGN provided by MarketBeat
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target lowered by analysts at JPMorgan Chase & Co. from $18.00 to $17.00. They now have an "underweight" rating on the stock.
Ratings data for MYGN provided by MarketBeat
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target lowered by analysts at JPMorgan Chase & Co. from $17.00 to $14.00. They now have an "underweight" rating on the stock.
Ratings data for MYGN provided by MarketBeat
Myriad Genetics, Inc. (NASDAQ: MYGN) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $28.00 price target on the stock.
Ratings data for MYGN provided by MarketBeat
Myriad Genetics, Inc. (NASDAQ: MYGN) is now covered by analysts at Guggenheim. They set a "buy" rating and a $23.00 price target on the stock.
Ratings data for MYGN provided by MarketBeat
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $28.00 to $31.00. They now have a "buy" rating on the stock.
Ratings data for MYGN provided by MarketBeat
Neueste Beiträge
Loop_Capital in Crown Holdings Inc. diskutieren